Early Toxicity Testing Market Introduction and Overview
According to SPER Market Research, the Global Early Toxicity Testing Market is estimated to reach USD 2.58 billion by 2033 with a CAGR of 7.41%.
The report includes an in-depth analysis of the Global Early Toxicity Testing Market, including market size and trends, product mix, applications, and supplier analysis. The Early Toxicity Testing is an important industry in the pharmaceutical and biotechnology industries, assessing the potential toxicity of new therapeutic compounds during the early stages of development. This market includes a variety of approaches and technologies designed to detect any negative effects of medication candidates early in the research and development process. Early toxicity testing is performed at the pre-clinical phases of a drug development process and is critical since toxicity is the primary cause of the failure of potential drug candidates in the later stages of drug development, resulting in significant financial losses for companies.
- June 2020: Charles River Laboratories acquired MPI Research for $800 million.
- August 2020: Eurofins Scientific acquired Bio Reliance for $400 million.
Market Opportunities and Challenges
Growing R&D activities in the healthcare sector, as well as stringent regulatory requirements, necessitate toxicity testing for newly produced therapeutic medications. The global early toxicity testing market is being driven by advanced technology usage in toxicity testing conducted at newly formed and developing clinical research organizations. Pharmaceutical companies are attempting to discover potential toxicity of candidate compounds early on, which aids in the research of medication pharmacokinetics and pharmacodynamic features, as well as many safety endpoints, resulting in large-scale manufacturing of fully efficient and safe drugs.
Early toxicity testing acquires traction as a result of the high frequency of drug failures in the later stages of drug testing. These stages are exceedingly expensive to accomplish, and failure results in even more financial losses for the organization. More consistency is required in toxicity testing methodologies, which might lead to variable results and make data comparison difficult. This factor limits market growth. Toxicity testing necessitates a high level of knowledge, and there is frequently a scarcity of skilled persons available to perform the tests.
Market Competitive Landscape
To maintain their position in the early toxicity testing market, major players are pursuing expansion and acquisition tactics across many geographies. Key players are Agilent Technologies, Accelrys, BD bioscience, Bio-rad, Bioanalytical Systems, Charles River Laboratories, Evotec AG Enzo Biochem Inc, Eurofins Scientific.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Technique, By End User.
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Agilent Technologies, Accelrys, BD bioscience, Bio-rad, Bioanalytical Systems, Charles River Laboratories, Evotec AG Enzo Biochem Inc, Eurofins Scientific |
COVID-19 Impact on Global Early Toxicity Testing Market
The pandemic highlighted the significance of early toxicity testing in drug development, resulting in increasing demand for testing services and technologies. Companies working on COVID-19 medicines and vaccines needed to do rapid and extensive toxicity testing to shorten development times and ensure safety. With the urgent need to create COVID-19 therapies and vaccines, the pharmaceutical and biotechnology sectors' research objectives have shifted. Many businesses shifted money and efforts to COVID-19 research, perhaps influencing the pace and focus of early toxicity testing for additional drug candidates.
Key Target Audience:
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutions
- Regulatory Agencies (e.g., FDA, EMA)
- Healthcare Institutions
- Toxicology Laboratories
- Animal Testing Facilities
- Government Agencies (e.g., NIH, CDC)
- Environmental Health and Safety Departments
Our in-depth analysis of the Early Toxicity Testing Market includes the following segments:
|
By Technique: |
In vivo
In silico
In vitro
|
|
By End User: |
Pharmaceuticals industry
Cosmetics industry
Chemicals industry
Food industry
Others
|
|
By Region:
|
Asia-Pacific
Europe
Middle East & Africa
North America
Latin America
|
Key Topics Covered in the Report:
- Global Early Toxicity Testing Market Size (FY’2024-FY’2033)
- Overview of Global Early Toxicity Testing Market
- Segmentation of Global Early Toxicity Testing Market By Technique (In vivo, In silico, In vitro.)
- Segmentation of Global Early Toxicity Testing Market By End User (Pharmaceuticals industry, Cosmetics industry, Chemicals industry, Food industry, Others.)
- Statistical Snap of Global Early Toxicity Testing Market
- Expansion Analysis of Global Early Toxicity Testing Market
- Problems and Obstacles in Global Early Toxicity Testing Market
- Competitive Landscape in the Global Early Toxicity Testing Market
- Impact of COVID-19 and Demonetization on Global Early Toxicity Testing Market
- Details on Current Investment in Global Early Toxicity Testing Market
- Competitive Analysis of Global Early Toxicity Testing Market
- Prominent Players in the Global Early Toxicity Testing Market
- SWOT Analysis of Global Early Toxicity Testing Market
- Global Early Toxicity Testing Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Early Toxicity Testing Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Early Toxicity Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Early Toxicity Testing Market
7. Global Early Toxicity Testing Market, By Technique (USD Million) 2020-2033
7.1. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2020-2026
7.2. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2027-2033
7.3. In vivo
7.4. In silico
7.5. In vitro
8. Global Early Toxicity Testing Market, By End User (USD Million) 2020-2033
8.1. Global Early Toxicity Testing Market Size, Share and Forecast, By End User, 2020-2026
8.2. Global Early Toxicity Testing Market Size,Share and Forecast, By End User, 2027-2033
8.3. Pharmaceuticals industry
8.4. Cosmetics industry
8.5. Chemicals industry
8.6. Food industry
8.7. Others
9. Global Early Toxicity Testing Market Forecast, 2020-2033 (USD Million)
9.1. Global Early Toxicity Testing Market Size and Market Share
10. Global Early Toxicity Testing Market, By Region, 2020-2033 (USD Million)
10.1. Global Early Toxicity Testing Market Size and Market Share By Region (2020-2026)
10.2. Global Early Toxicity Testing Market Size and Market Share By Region (2027-2033)
10.3. Asia-Pacific
10.3.1. Australia
10.3.2. China
10.3.3. India
10.3.4. Japan
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific
10.4. Europe
10.4.1. France
10.4.2. Germany
10.4.3. Italy
10.4.4. Spain
10.4.5. United Kingdom
10.4.6. Rest of Europe
10.5. Middle East and Africa
10.5.1. Kingdom of Saudi Arabia
10.5.2. United Arab Emirates
10.5.3. Qatar
10.5.4. South Africa
10.5.5. Egypt
10.5.6. Morocco
10.5.7. Nigeria
10.5.8. Rest of Middle East & Africa
10.6. North America
10.6.1. Canada
10.6.2. Mexico
10.6.3. United States
10.7. Latin America
10.7.1. Argentina
10.7.2. Brazil
10.7.3. Rest of Latin America
11. Company Profile
11.1. Agilent Technologies
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Accelrys
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. BD bioscience
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Bio-rad
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Bioanalytical Systems
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Charles River Laboratories
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Evotec AG
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Enzo Biochem Inc
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Eurofins Scientific
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
